Genomics

Dataset Information

0

H3K27ac ChIP-seq analysis of human breast cancer cell lines treated with abemaciclib, fulvestrant

ABSTRACT: H3K27ac ChIP-seq analysis of human breast cancer cell lines treated with abemaciclib, fulvestrant

PROVIDER: PRJNA660462 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR12557875.fastq.gz Fastqsanger.gz
SRR12557876.fastq.gz Fastqsanger.gz
SRR12557877.fastq.gz Fastqsanger.gz
SRR12557878.fastq.gz Fastqsanger.gz
SRR12557879.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 8

Similar Datasets

Genomics H3K27ac ChIP-seq analysis of human breast cancer cell lines treated with abemaciclib, fulvestrant
2020-09-01 | GSE157222 | GEO
Genomics Enhancer connectome analysis of human breast cancer cell lines treated with abemaciclib
2020-09-03 | GSE157381 | GEO
Transcriptomics RNA-seq analysis of human breast cancer cell lines treated with abemaciclib
2020-09-03 | GSE157383 | GEO
Genomics ATAC-seq analysis of human breast cancer cell lines treated with abemaciclib
2020-08-31 | GSE157082 | GEO
Genomics H3K9me3 ChIP-seq analysis of human breast cancer cell lines treated with abemaciclib
2020-08-31 | GSE157097 | GEO
Transcriptomics Transcriptional reprogramming underpinning resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer cell lines
2023-06-05 | GSE227102 | GEO
Genomics ATAC-seq analysis of human breast cancer cell lines treated with abemaciclib
| PRJNA660031 | ENA
Genomics Enhancer connectome analysis of human breast cancer cell lines treated with abemaciclib
| PRJNA661087 | ENA
Genomics RNA-seq analysis of human breast cancer cell lines treated with abemaciclib
| PRJNA661088 | ENA
Transcriptomics RNA-seq of human breast cancer cell lines MCF7 and T74D naive and resistant to palbociclib treated with capivasertib, fulvestrant and combination
2023-08-14 | E-MTAB-13262 | biostudies-arrayexpress